NASDAQ:BRKR - Bruker Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$30.19 +0.47 (+1.58 %)
(As of 07/22/2018 11:07 AM ET)
Previous Close$30.19
Today's Range$29.56 - $30.32
52-Week Range$26.98 - $36.53
Volume995,021 shs
Average Volume564,984 shs
Market Capitalization$4.71 billion
P/E Ratio24.95
Dividend Yield0.53%
Beta1.17
Bruker logoBruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Debt-to-Equity Ratio0.26
Current Ratio2.22
Quick Ratio1.29

Price-To-Earnings

Trailing P/E Ratio24.95
Forward P/E Ratio21.88
P/E Growth1.94

Sales & Book Value

Annual Sales$1.77 billion
Price / Sales2.67
Cash Flow$1.6479 per share
Price / Cash18.32
Book Value$4.72 per share
Price / Book6.40

Profitability

EPS (Most Recent Fiscal Year)$1.21
Net Income$78.60 million
Net Margins4.63%
Return on Equity27.04%
Return on Assets10.69%

Miscellaneous

Employees6,200
Outstanding Shares156,080,000
Market Cap$4,712.12

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Tuesday, May 15th. Shareholders of record on Monday, June 4th will be paid a dividend of $0.04 per share on Friday, June 22nd. This represents a $0.16 annualized dividend and a yield of 0.53%. The ex-dividend date is Friday, June 1st. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker declared that its board has initiated a stock buyback plan on Sunday, June 4th 2017, which permits the company to repurchase $225,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board believes its stock is undervalued.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) posted its earnings results on Thursday, May, 3rd. The medical research company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.22 by $0.02. The medical research company earned $431.70 million during the quarter, compared to the consensus estimate of $419.25 million. Bruker had a net margin of 4.63% and a return on equity of 27.04%. The firm's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.19 EPS. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Bruker.

What price target have analysts set for BRKR?

9 brokers have issued 1 year price objectives for Bruker's stock. Their predictions range from $24.00 to $42.00. On average, they anticipate Bruker's stock price to reach $32.8889 in the next twelve months. This suggests a possible upside of 8.9% from the stock's current price. View Analyst Ratings for Bruker.

What is the consensus analysts' recommendation for Bruker?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Bruker's key competitors?

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 58)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 56)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 63)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 60)
  • Stacey Desrochers, Treasurer & Director of Investor Relations

Has Bruker been receiving favorable news coverage?

News articles about BRKR stock have been trending somewhat positive on Sunday, Accern Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Bruker earned a coverage optimism score of 0.07 on Accern's scale. They also gave news stories about the medical research company an impact score of 47.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Bruker's major shareholders?

Bruker's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Scout Investments Inc. (0.12%), Cambiar Investors LLC (0.10%), Thompson Rubinstein Investment Management Inc. OR (0.09%), Fisher Asset Management LLC (0.09%), Clinton Group Inc. (0.03%) and Fox Run Management L.L.C. (0.02%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch, Richard A Packer and Richard Kniss. View Institutional Ownership Trends for Bruker.

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Fisher Asset Management LLC and Scout Investments Inc.. View Insider Buying and Selling for Bruker.

Which institutional investors are buying Bruker stock?

BRKR stock was acquired by a variety of institutional investors in the last quarter, including Clinton Group Inc., Cornerstone Wealth Management LLC, Fox Run Management L.L.C., Thompson Rubinstein Investment Management Inc. OR and State of Alaska Department of Revenue. Company insiders that have bought Bruker stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $30.19.

How big of a company is Bruker?

Bruker has a market capitalization of $4.71 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (NASDAQ BRKR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  477 (Vote Outperform)
Underperform Votes:  529 (Vote Underperform)
Total Votes:  1,006
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.